DAX25.284 ±-0,0%Est506.138 -0,4%MSCI World4.343 -0,1%Top 10 Crypto8,4900 -2,9%Nas22.668 -0,9%Bitcoin55.840 +0,2%Euro1,1806 ±0,0%Öl72,48 +2,2%Gold5.278 +1,9%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
NVIDIA 918422 Siemens Energy ENER6Y Novo Nordisk A3EU6F SAP 716460 Deutsche Telekom 555750 freenet A0Z2ZZ Rheinmetall 703000 BASF BASF11 Allianz 840400 DroneShield A2DMAA Netflix 552484 Lufthansa 823212 Infineon 623100 Bayer BAY001 Gerresheimer A0LD6E
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen schließen im Minus -- DAX geht stabil ins Wochenende -- Netflix steigt aus Warner-Bieterkampf aus -- BASF für 2026 vorsichtig -- Delivery Hero: Umsatz enttäuscht -- 1&1, AIXTRON im Fokus
Top News
Februar 2026: So schlugen die TecDAX-Aktien im vergangenen Monat aus Februar 2026: So schlugen die TecDAX-Aktien im vergangenen Monat aus
DAX in KW 9: Diese Aktien gehörten zu den Gewinnern und Verlierern DAX in KW 9: Diese Aktien gehörten zu den Gewinnern und Verlierern
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Telix Pharmaceuticals Aktie

Kaufen
Verkaufen
6,50 EUR +0,85 EUR +15,04 %
FSE
7,23 USD -0,28 USD -3,73 %
nachbörslich
BTT
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone
Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA40FCQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS87961M1053

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolTLX

Telix Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
PR NewswireNOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
PR NewswireTelix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
PR NewswireTelix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
PR NewswireFirst Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients
PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline
PR NewswireTelix to Add FAP-Targeting Candidates to Theranostic Pipeline
PR NewswireTelix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
PR NewswireTelix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
PR NewswireTelix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
PR NewswireFDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
PR NewswireTelix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
PR NewswireTelix Files Form 20-F Registration Statement for Nasdaq ADS
PR NewswireTelix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M
PR NewswireTelix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)
PR NewswireAustralian TGA Approves Additional Indication for Telix's Illuccix® to Include Patient Selection for PSMA-Targeted Therapy
PR NewswireFirst Patient Dosed in Phase II 'CA-NINE' Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery
PR NewswireTelix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
PR NewswireTelix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
PR NewswireTelix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
PR Newswire'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
PR Newswire'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
PR NewswireIPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
PR NewswireIPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
PR NewswireTelix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
PR NewswireTelix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
PR NewswireTelix Announces Reorganisation to Deliver on Strategic Priorities
PR NewswireTelix Announces Reorganisation to Deliver on Strategic Priorities
PR NewswireTelix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities
PR NewswireFDA Accepts Telix NDA for New Prostate Cancer Imaging Agent
PR NewswireTelix Successfully Prices A$650 Million Convertible Bonds
PR NewswireTelix Announces A$600 Million Convertible Bonds Offering
PR NewswireTelix Pharmaceuticals Q2 2024 Revenue and Business Highlights, Guidance Upgrade
PR NewswireTelix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals

Telix Pharmaceuticals News

Telix Pharmaceuticals News: auf dieser Seite finden Sie alle Telix Pharmaceuticals News und Nachrichten zur Telix Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Telix Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Telix Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.